Jenburkt Pharmaceuticals Ltd — Board Meeting, 12-08-2025: Board Meeting

Jenburkt Pharmaceuticals' Board of Directors has approved the financial results for the quarter ended June 30, 2025. The company reported revenue from operations of Rs 35.53 Cr and a profit after tax of Rs 7.79 Cr for the quarter. The Audit Committee reviewed these results, which were also subject to a limited review by the company's auditors. This update provides key insights into the company's recent financial performance, offering shareholders a clear overview of its business status.